Cite
Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314–1320].
MLA
Wen, Dacheng, et al. “Retraction Notice to "MiR-539 Inhibits Human Colorectal Cancer Progression by Targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314–1320].” Biomedicine & Pharmacotherapy, vol. 167, Nov. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.115375.
APA
Wen, D., Li, S., Jiang, W., Zhu, J., Liu, J., & Zhao, S. (2023). Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314–1320]. Biomedicine & Pharmacotherapy, 167, N.PAG. https://doi.org/10.1016/j.biopha.2023.115375
Chicago
Wen, Dacheng, Songhe Li, Weidong Jiang, Jiaming Zhu, Jingjing Liu, and Shutao Zhao. 2023. “Retraction Notice to "MiR-539 Inhibits Human Colorectal Cancer Progression by Targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314–1320].” Biomedicine & Pharmacotherapy 167 (November): N.PAG. doi:10.1016/j.biopha.2023.115375.